NEW YORK (TheStreet) -- Shares of Zeltiq Aesthetics (ZLTQ) are surging 30.56% to $21.66, hitting a six month high today, after releasing positive second quarter earnings and an upbeat full year outlook, helped by increasing momentum in CoolSculpting sales, its fat cell removal devices.
The company reported net income for the second quarter of 2014 of $2.8 million, or 7 cents per share, up from a net loss of $3.6 million, or -10 cents per share in the same quarter the previous year, and beating analysts' consensus estimate of -13 cents by 20 cents.
Revenue for the second quarter was up 79.1% from the same quarter of 2013 at $47.1 million, beating the consensus estimate of $34.93 million.
Must Read: Warren Buffett's 25 Favorite StocksSTOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. The medical device development company increased its full year 2014 revenue guidance to $160 million and $165 million, up from the prior $137 million to $140 million, and more than the consensus of $140.1 million.
ZLTQ data by YCharts
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts